Global cancer statistics, 2002

Ca-A Cancer Journal for Clinicians

Volumn 55, Issue 2, 2005, Pages 74-108

  Parkin, D Max ^a   Bray, Freddie ^a   Ferlay, J ^a   Pisani, Paola ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER STATISTICS; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; ENVIRONMENTAL EXPOSURE; GEOGRAPHIC DISTRIBUTION; HODGKIN DISEASE; HUMAN; INTERNATIONAL COOPERATION; KAPOSI SARCOMA; LARYNX CANCER; LEUKEMIA; LIFESTYLE; LIVER CANCER; LUNG CANCER; MELANOMA; MYELOMA; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; STOMACH CANCER; SURVIVAL TIME; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

EID: 14944385553     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.55.2.74     Document Type: Review

References (93)

1. Parkin DM, Stjernswörd J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull WHO 1984;62:163-182.
2. Parkin DM, Bray F, Devesa S. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001;37:S4-S66.
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Lyon, France: International Agency for Research on Cancer; 2001.
4. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon, France: IARC-Press; 2004.
5. Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 cancers in the adult population. Int J Cancer 2002;97:72-81.
6. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999;80:827-841.
7. Pisani P, Parkin DM, Bray Fl, Ferlay J. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Implications for prevention, and projections of future burden. Int J Cancer 1999;83:18-29.
8. Smith P. Comparison between Registries: Age Standardised Rates, in Cancer Incidence in Five Continents, Vol. V, IARC Scientific Publications No. 88. Lyon, France: International Agency for Research on Cancer; 1987.
9. Sant M, Aareleid T, Berrino F, et al. EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003; 14:v61-v118.
10. Ries LAG, Eisner MP, Kosary CL, et al. (eds). SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/csr/1975_2001/. Accessed December 22, 2004.
11. Gondos A, Chokunonga E, Brenner H, et al. Cancer survival in a Southern African urban population. Int J Cancer 2004;112:860-864.
12. Gondos A, Brenner H, Wabinga H, et al. Cancer survival in Kampala, Uganda. Br J Cancer 2005 (in press).
13. Sankaranarayanan R, Black RJ, Parkin DM eds). Cancer Survival in Developing Countries, IARC Scientific Publications No. 15. Lyon, France: International Agency for Research on Cancer; 1988.
14. United Nations. World population prospects. The 2002 Revision. Population database. New York, NY: United Nations; 2003. Available at: Accessed December 22, 2004.
15. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention, and projections of future burden. Int J Cancer 1993;55:891-903.
16. Parkin DM, Hakulinen T. Analysis of survival In: Jensen OM, Parkin DM, Maclennan R, et al. (eds). Cancer Registration, Principles and Methods, IARC Scientific Publications No. 95. Lyon, France: International Agency for Research on Cancer: 1991:159-176.
17. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
18. Doll R, Peto R. The Causes of Cancer. Oxford, UK; Oxford University Press; 1981.
19. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994;59:494-504.
20. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries, 1950-2000. Oxford, UK: Oxford University Press; 1994.
21. Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 2001;93:277-283.
22. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic in the 15 European Union countries 1967-1999. Eur J Cancer 2004;40:96-125.
23. Tyczynski JE, Bray F, Aareleid T, et al. Lung cancer mortality patterns in selected Central, Eastern and Southern European countires. Int J Cancer 2004;109:598-610.
24. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3-27.
25. IARC Handbook on Cancer Prevention No. 7. Breast Cancer Screening. Lyon, France: International Agency for Research on Cancer; 2002.
26. Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999;91:1480-1486.
27. McPherson K, Steel CM, Dixon JM. Breast cancer - epidemiology, risk factors and genetics. Brit Med J 2000;321:624-628.
28. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 1975;15:617-631.
29. Prentice RL, Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1990;1:81-87.
30. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3:687-695.
31. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31:925-943.
32. McMichael AJ, McCall MG, Hartchorne JM. Woodings TL. Patterns of gastrointestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 1980; 5:431-437.
33. Kolonel LN, Hinds MW, Hankin JH. Cancer Patterns among Migrant and Native-born Japanese in Hawaii in Relation to Smoking, Drinking and Dietary Habits. In: Gelboin HV, MacMahon B, Matsushima T, et al. (eds). Genetic and Environmental factors in Experimental and Human Cancer. Tokyo, Japan: Japan Scientific Societies Press; 1980:327-340.
34. Parkin DM, Whelan SL, Ferlay J, et al. (eds). Cancer Incidence in Five Continents. Vol. VIII, IARC Scientific Publications No. 155. Lyon, France: International Agency for Research on Cancer; 2002.
35. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992;33:429-431.
36. Parkin DM, Ferlay J, Hamdi-Chérif M, et al. (eds). Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications No. 153. Lyon, France: International Agency for Research on Cancer; 2003.
37. Coggon D, Osmond C, Barker DJ. Stomach cancer and migration with England and Wales. Br J Cancer 1990;61:573-574.
38. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Schistosomes, Liver Flukes and helicobacter pylori. Lyon, France: International Agency for Research on Cancer; 1994.
39. Sitas F, Yarnell J, Forman D. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 1992;33:1582.
40. World Cancer Research Fund (WCRF) Panel. Diet, nutrition and the prevention of cancer: a global perspective. Washington, DC, USA: World Cancer Research Fund; 1997.
41. Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 2000;35:S84-S89.
42. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 83: Tobacco Smoke and Involuntary Smoking. Lyon, France: International Agency for Research on Cancer; 2004.
43. Muñoz N, Franceschi S. Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex 1997;39:318-330.
44. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-221.
45. Roosendaal R, Kulpers EJ, Buiterwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480-1482.
46. Miller BA, Kolonel LN, Bernstein L, et al., eds. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. NIH Publication No. 96-4104. Bethesda, MD: National Cancer Institute; 1996.
47. Bouchardy C, Mirra AP, Khlat M, et al. Ethnicity and cancer risk in Sao Paulo, Brazil. Cancer Epidemiol Biomarkers Prev 1991;1:21-27.
48. Shibata A, Whittemore A. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 1997;32:65-72.
49. Potosky AL, Kessler Gridley G, et al. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Caner Inst 1990;82:1624-1628.
50. Brawley OW. Prostate carcinoma incidence and patient mortality. The effects of screening and early detection. Cancer 1997;80:1857-1863.
51. Chu KC, Tarone RE, Freeman HP. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003; 97:1507-1516.
52. Hsing AW, Tsao L, Devesa SS. International trends and patterns of cancer incidence and mortality. Int J Cancer 2000;85:60-67.
53. Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the 'PSA era'. Int J Cancer 2001;92:893-898.
54. Baade PD, Coory MD, Aitken JF. International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 2004;15:237-241.
55. Donato F, Boffetta P, Puoti MA. Meta-analysis of epidemiological studies on the combined effect of Hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-354.
56. Tanaka H, Hiyama T, Tsukuma H, et al. Prevalence of second generation antibody to hepatits C antibody among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994;5:409-413.
57. Parkin DM, Pisani P, Muñoz N, Ferlay J. The Global Health Burden of Infection Associated Cancer, in Weiss RA, Beral V, Newton R (eds). Infections and Human Cancer. Cancer Surveys 1999;33:5-33.
58. Parkin DM, Ohshima H, Srivatanukul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenese and prevention. Cancer Epidemiol Biomarkers Prev 1993;2:537-544.
59. Chang MH, Chen CJ, Lai MS, et al. Universal Hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
60. Gustafsson L. Pontén J, Bergström R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997;71:159-165.
61. Dorn HF, Cutler SJ. Morbidity from cancer in the United States: Parts I and II. Public Health Monograph No. 56. Washington, DC: US Department of Health, Education, and Welfare; 1959.
62. Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil. Results of a population-based cancer registry from Iran. Int J Cancer 2003;107:113-118.
63. Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
64. Muñoz N, Bosch FX, Shah KV, Meheus A. The epidemiology of cervical cancer and human papillomavirus. IARC Scientific Publication No. 119. Lyon, France: International Agency for Research on Cancer; 1992.
65. Pham THA, Nguyen NT, Herrero R, et al. Human papillomavirus infection among women in south and North Vietnam. Int J Cancer 2002;104:213-230.
66. Muñoz N, Day N. Esophageal Cancer, in Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996.
67. Yokoyama A, Kato H, Yokoyama T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenase and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men and esophageal squamous cell carcinoma. Carcinogenesis 2002;23:1851-1859.
68. Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Human Genet 1992; 88:344-346.
69. Vizcaino AP, Moreno V, Lambert R, et al. Time trends in incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1975. Int J Cancer 2002;99:860-868.
70. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-155.
71. Lagergren J, Bergström R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardis. Ann Intern Med 1999;130:883-890.
72. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Caner Inst 1994; 86:712-716.
73. Yu MC, Ross RK, Chan KK, et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995; 4:861-864.
74. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumors. Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2001.
75. Remick SC. Acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Cancer Control 1995;2:97-103.
76. Melbye M, Trichopoulos D. Non-Hodgkin's lymphomas, in Adami HO, Hunter D, Trichopoulos D (eds). Textbook of Cancer Epidemiology. Oxford, UK: Oxford University Press; 2002.
77. Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000;85:319-324.
78. Harge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992;52:5566s-5569s.
79. Eltorn MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1988. J Natl Cancer Inst 2002; 94:1204-1210.
80. Bergström A, Pisani P, Wolk A, et al. Over-weight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-430.
81. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 72, Hormonal Contraception and Postmenopausal Hormonal Therapy. Lyon, France: International Agency for Research on Cancer, 1999.
82. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France: International Agency for Research on Cancer; 1997.
83. Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarker Prev 1992; 1:261-268.
84. Mueller NE. Hodgkin's Disease, in Schottenfeld D, Fraumeni JF, Jr (eds). Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996:893-919.
85. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375-382.
86. Oettlé AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Conra Cancrum 1962;18:330-363.
87. Templeton AC. Kaposi's Sarcoma, in Sommers SC, Rosen PP (eds). Pathology Annual. New York: Century-Crofts; 1981:315-336.
88. Biggar RJ, Horn J, Fraumeni JF, et al. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-1981. J Natl Cancer Inst 1984;73:89-94.
89. Rabkin CS, Biggar RJ, Horn JW. Increasing incidence of cancer associated with the human immunodeficiency virus epidemic. Int J Cancer 1991;47:692-696.
90. Sriplung H, Parkin DM. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 2004; 101:2660-2666.
91. Newton R, Sitas F, Dedicoat M, Ziegler JL. HIV infection and Cancer, in Essex M, Mboup S, Kanki PJ, et al. (eds). AIDS in Africa. 2nd ed. New York: Kluwer Academic; 2002.
92. Sitas F, Pacella-Norman R, Carrara H, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000;88:489-492.
93. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-1830.